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The purpose of our study was to examine left ventricular myocyte Ca homeostasis, contraction, and sarcolemmal permeability in myocytes from MLP-deficient mice in order to investigate possible mechanisms by which cytoskeletal abnormalities might result in cardiomyopathy and heart failure.
MATERIAL AND METHODS
MLPKO mice. MLPKO mice were produced as previously described (1). MLPKO and age-matched littermate [wild type (WT)] mice, 6 Ϯ 1 mo old, were used for experiments.
Dissociation of adult mouse ventricular myocytes. Adult mouse myocyte isolations were enzymatically performed as previously described (33) . Briefly, hearts were removed from anesthetized mice and immediately attached to an aortic cannula. After hearts were perfused with Ca 2ϩ -free modified Tyrode solution containing (in mM) 126 NaCl, 4.4 KCl, 1.0 MgCl2, 18 NaHCO3, 11 glucose, and 4 HEPES for 5 min, they were digested with 0.90 mg/ml collagenase D (BoehringerMannheim Biochemicals) in 25 M CaCl 2-containing modified Tyrode solution for 7-12 min, which also contained 30 mM 2,3-butanedione monoxime (BDM) and 0.13 U/ml insulin. In some experiments, BDM was omitted from the dissociation solution. The digested hearts were removed from the cannula, and the left ventricles were cut into small pieces in 100 M Ca 2ϩ modified Tyrode solution. The cell suspension was then centrifuged at 300 rpm for 3 min, and the pellet of the cells was resuspended in 200 M Ca 2ϩ and 2% albuminTyrode solution and allowed to settle for 20 min at 30°C. The cells were then resuspended in 0.9 mM Ca 2ϩ culture media composed of 50% minimal essential medium (GIBCO-BRL Laboratories), 50% modified Tyrode solution without BDM, 10 mM pyruvic acid, and 6.1 mM glucose at 30°C in a 5% CO 2 atmosphere until use. Isolated cells were all used for experiments within 6 h after isolation. ]i) in isolated myocytes was measured with fluo 3 as previously described (32, 33) . Myocytes attached to laminin-coated glass coverslips were incubated in a 1 M fluo 3-AM (Molecular Probes)-containing HEPES solution (loading solution) at 30°C in the dark for 30 min.
Measurement of intracellular
Fluo 3-loaded myocytes were excited by a mercury arc lamp system at a 485-nm wavelength through an epifluorescence attachment (505-nm dichroic mirror, Omega) and a ϫ40 Fluor oil objective lens (Nikon). Fluorescence (530 nm, DF30, Omega) was detected with a photomultiplier tube (Hitachi). Calibration of the [Ca 2ϩ ]i transients was performed by superfusing the myocyte with 10 M ionomycin, 10 mM MnCl2, and 30 mM BDM-containing HEPES solution. The maximum fluorescence (Fmax) was calculated with the formula Fmax ϭ FMn2ϩ ϫ 5, where FMn2ϩ is the fluorescence in the presence of Mn 2ϩ . Minimum fluorescence (Fmin) was 1/40 of Fmax. Therefore, [Ca 2ϩ ]i could be calculated with the following formula: [Ca 2ϩ ]i ϭ Kd ϫ (F Ϫ Fmin)/(Fmax Ϫ F). In this formula, F is the measured fluorescence intensity of the myocyte corrected for background and autofluorescence, and Kd is the dissociation constant (493 nM) (33) . All experiments on [Ca 2ϩ ]i were performed at 25°C. In some experiments, we measured intracellular fluo 3 F/F0 (where F0 is resting fluorescence intensity) to quantitate peak [Ca 2ϩ ]i (7). The intracellular Na ϩ concentration ([Na ϩ ]i) was measured with 1,3-benzenedicarboxylic acid, 4,4Ј-[1,4,10-trioxa-7,13-diazacyclopentadecane-7,13-diylbis(5-methoxy-6,12-benzofurandiyl)]bis-, tetrakis[(acetyloxy)methyl] ester (SBFI-AM) as previously described (33) . After myocytes were loaded by incubation for 120 min in 10 M SBFI-AM, myocytes were illuminated sequentially at 60 Hz by 340-and 380-nm excitation light passing through band-pass filters (P10-340 and P10-380, Corion) with an optical switcher (DX-1000, Solamere Technology Group), and the fluorescence at 510 nm (P10-510, Corion) was continuously recorded. The ratio of the fluorescence intensity during excitation with 340-and 380-nm light (R) was used as an indicator for [Na ϩ ]. The myocyte was sequentially exposed to three calibration solutions of 5, 10, and 15 mM Na ϩ , which contained (in M) 2 gramicidin-D, 40 monensin, and 100 strophanthidin. In each solution, [ ]i and shortening during tetanus (34) .
L-type Ca 2ϩ channel current and Na/Ca exchanger current measurements. L-type Ca 2ϩ current (ICa,L) and Na/Ca exchanger current (I Na/Ca) were consecutively measured as previously described (29, 32, 33 in the solution was brought to 130 mM by adding CsCl. After the myocyte was stabilized at Ϫ80 mV for 3 min, the myocyte was held at a potential of Ϫ40 mV, and ICa,L was then activated by depolarizing the myocyte membrane to more positive values for 500 ms. After ICa,L was measured and after 20 min had passed after starting dialysis, the myocyte was abruptly exposed to Na ϩ -free solution at a holding potential of Ϫ40 mV for 5 s with a solenoid-based rapid solution switcher, which can change the bulk solution surrounding the myocyte within 4 ms (31). This procedure elicits an outward current due to reverse Na/Ca exchange (3 Na ϩ out, 1 Ca 2ϩ in), the magnitude of which can be used to estimate Na/Ca exchanger density (29) when normalized by cell membrane capacitance.
Measurement of sarcoplasmic reticulum Ca content. Sarcoplasmic reticulum (SR) Ca 2ϩ content was determined by measuring the integral of the caffeine-induced inward I Na/Ca (33) . In brief, myocytes were voltage clamped at Ϫ80 mV with a single suction pipette filled with a solution composed of (in mM) 15 NaCI, 100 CsCl, 30 tetraethylammonium chloride, 5 MgATP, 10 HEPES, and 5.5 dextrose (pH 7.1 adjusted with CsOH). The voltage-clamped cell was then superfused in microstream with a solution containing (in mM) 126 NaCl, 4.4 KCl, 1.0 MgCl2, 1.08 CaCl2, 2 CsCl, 0.1 BaCl2, 11 dextrose, and 24 HEPES (pH 7.4 adjusted with NaOH to give a final [Na ϩ ]o of 140 mM). After a train of steady-state conditioning pulses (eight 200-ms pulses to 0 mV at 0.25 Hz), the myocyte was abruptly immersed for 6 s in an adjacent switcher solution microstream in which 10 mM caffeine was added to release SR Ca . On the basis of the stoichiometry of the electrogenic Na/Ca exchange (3:1), the integral (nA ϫ ms ϭ pC) of the resulting inward INa/Ca was converted to the amount of Ca 2ϩ (in pmol) extruded by Na/Ca exchange during the sustained exposure of cells to caffeine and normalized by cell capacitance (in pF). The decline of the current curve was well fitted with a single exponential, with a time constant of [Ca 2ϩ ]i decline () value Ϸ 500 ms under our experimental conditions. The current values at greater than five times (Ϸ2,500 ms) from the peak of the current were used as a baseline for current transient integration.
For analysis, all records of [Ca 2ϩ ]i transients, currents, and pacing signals were simultaneously digitized and acquired at the sampling rate of 1 kHz (Axo Scope, Axon Instruments). Currents were analyzed with pCLAMP6.0 software (Axon Instruments), and digitized [Ca 2ϩ ]i transients were analyzed with Origin (Microcal).
Immunofluorescence and cell size analysis. To examine the organization of the contractile elements, we stained actin filaments with tetramethylrhodamine isothiocyanate (TRITC)-labeled phalloidin (Sigma). After isolation, myocytes attached on laminin-coated coverslip were fixed with 3.7% formaldehyde, permeabilized in 0.5% Triton X-100 in PBS, and blocked with 10% goat serum in PBS plus 0.1% Tween 20. Cells were then stained with TRITC-labeled phalloidin (Sigma) (40 mg/ml in PBS containing 2 mg/ml BSA, 1% DMSO, and 0.5% NP-40), and the myocytes were washed with 0.1% Tween 20 in PBS and examined with a confocal microscope (MRC 2000, Bio-Rad). Stained myocytes were excited at 488 nm with an argon laser, and 530-nm emission light was collected to create images. In other experiments, nonfixed freshly dissociated myocytes were imaged during bright field illumination with an intensified video camera (XR GEN3, Solamere Technology). Myocyte area was then calculated from measurement of cell length and width.
Sarcolemmal cation permeability. To assess permeability of the sarcolemma of MLPKO and WT myocytes to cations, we loaded cells with fura 2 by incubating them in 1 M fura 2-AM for 30 min. Myocytes were illuminated with 360-nm light (fura 2 Ca 2ϩ -insensitive isosbestic wavelength), and fluorescence was measured at 510 nm during exposure to 10 mM MnCl2. Mn 2ϩ quenches cytosolic fura 2 fluorescence, and thus the rate of decline of 510-nm fluorescence indicates the rate of entry of Mn 2ϩ into the cell. Statistical analysis. Results are expressed as means Ϯ SE; n ϭ the number of myocytes studied. Myocytes were obtained from at least four different hearts for every condition studied. A paired t-test was performed if the data were obtained from the same myocyte. Significance was tested by ANOVA if unpaired or multiple comparisons were made. A mixed-model ANOVA was employed, where strain is a fixed effect and the myocyte from a specific heart is the random effect. This analysis allows compensation for bias due to the fact that several myocytes from a given heart were studied by testing for an effect of isolation from a specific heart. Values of P Ͻ 0.05 were considered significant.
RESULTS
Cardiac enlargement in MLPKO mice. Data on left ventricular wet weight, lung weight, liver weight, and body weight in WT and MLPKO mice are summarized in Table 1 . The ratios of left ventricular wet weight and lung weight to body weight were significantly increased in MLPKO mice, confirming left ventricle enlargement and lung congestion. This result is consistent with a previous report (1) .
Myofilament organization. The gross appearance of intact myocytes isolated from the left ventricle of MLPKO hearts was abnormal. Freshly isolated MLPKO cells frequently had a slightly curved or "comma" shape. In fixed WT myocytes, myofibrils were clearly and well developed, and Z bands were regularly oriented through the myocyte (Fig. 1, A and B) . In contrast, in MLPKO myocytes, the sarcomere organization appeared abnormal: the lateral alignment of Z bands between adjacent myofilaments was impaired and the Z bands themselves were broader and less distinct than in WT cells (Fig. 1, C and D) .
[ graph (Fig. 3) ] i transient amplitude was enhanced in MLPKO myocytes, whereas FS was similar to WT myocytes as shown in Fig. 2 , it appeared that the sensitivity of shortening to Ca 2ϩ might be reduced in these myocytes. To confirm this, FS values at comparable peak [Ca 2ϩ ] i values were obtained from five WT myocytes exposed to 2.16 mM of Ca 2ϩ solution. The results are shown in Fig. 4 . The mean FS in MLPKO myocytes was significantly smaller compared with the FS at a comparable peak systolic [Ca 2ϩ ] i in WT myocytes. This suggests that the response of myofilaments to Ca Fig. 5 . Neither the current density nor the current-voltage relationship were altered, suggesting that the basic function of the L-type Ca 2ϩ channel is similar in MLPKO and WT mice.
Function of Na/Ca exchangers. Recently, we (33) reported that the reverse function of the Na/Ca exchanger can maintain Ca 2ϩ loading in mouse ventricular myocytes (33) . In human dilated cardiomyopathy, expression of the Na/Ca exchanger has been reported to be upregulated (28). Hence, it seemed possible that an upregulation of Na/Ca exchange could induce an increase in peak systolic [Ca 2ϩ ] i in MLPKO myocytes despite similar L-type Ca 2ϩ channel function. We therefore directly examined the function of the Na/Ca exchanger. As shown in Fig. 6 , the mean value of I Na/Ca density was similar between WT (n ϭ 15, 1.41 Ϯ 0.06 pA/pF) and MLPKO myocytes (n ϭ 6, 1.40 Ϯ 0.07 pA/pF). This indicates that the function and density of the Na/Ca exchanger are not altered in MLPKO myocytes. Table 2 ). The mean value for MLPKO cells fell within the range observed for WT myocytes. and subsequently the released Ca 2ϩ was removed via Na/Ca exchange, causing inward currents, as shown in Fig. 7 . The integral of the inward current normalized to membrane capacitance was somewhat increased in MLPKO myocytes [10. 72 Ϯ 0.78 (n ϭ 12) vs. 8.84 Ϯ 0.49 pmol/F (n ϭ 17) in WT myocytes], but this difference did not reach statistical significance (P ϭ 0.09). In these voltage-clamp measurements, there was no significant difference in capacitance between WT (n ϭ 32, 192 Ϯ 9 pF) and MLPKO myocytes (n ϭ 19, 199 Ϯ 11 pF), suggesting that the cells isolated from these hearts were not hypertrophied. This lack of hypertrophy of MLPKO myocytes was confirmed by measurement of myocyte length, width, and area (MLPKO myocytes: 102.9 Ϯ 1.6 m, 24.9 Ϯ 0. 4 (33) . Also, as shown in Fig. 8 , the rate of quenching of intracellular fura 2 by externally applied Mn 2ϩ was similar in MLPKO and WT cells. This suggests that sarcolemmal permeability is not markedly increased in MLPKO myocytes and is consistent with observations in two animals that in vivo myocyte permeability as assessed by uptake of Evans blue dye (27) is not increased in the MLPKO ventricle (Ross J, personal communication).
SR Ca content. Because the function of L-type
To examine [Ca 2ϩ ] i shortening relationships under more steady-state conditions than are present during a single contraction, we measured F/F o and FS in MLPKO and WT myocytes before and after 1.5 s and 3 min of pacing at 10 Hz in the presence of 5 M ryanodine. The results are shown in Table 3 . As before, during baseline pacing at 0.25 Hz, F/F o was significantly greater in MLPKO than WT myocytes, whereas FS was insignificantly lower in MLPKO cells. After 3 min of tetanization, there was no significant difference in F/F o or FS between MLPKO and WT myocytes. It appears that a maximal FS at steady state is achieved in both types of myocytes at the [Ca 2ϩ ] i levels obtained during rapid pacing in the presence of ryanodine.
Effects of BDM. Our results indicate that peak [Ca 2ϩ ] i levels are higher in MLPKO than WT myocytes, whereas Minamisawa et al. (17) reported the opposite. This difference could be due to differences in the dissociation techniques employed and possibly to the fact that right ventricular myocytes were studied in the experiments of Minamisawa et al. (17) . One difference in dissociation techniques is that we used BDM in our dissociation procedure for mouse ventricular myocytes to improve the yield (23) . We therefore examined [Ca 2ϩ ] i transients and FS in myocytes dissociated in the presence and absence of BDM. The results are shown in Table 4 . In MLPKO myocytes, both F/F o and FS were significantly greater in myocytes dissociated in the presence of BDM. Dissociation in BDM had no effect on F/F o in myocytes from normal mice. It is important to note that MLPKO myocytes dissociated without BDM had an insignificantly reduced F/F o compared with WT myocytes (2.4 Ϯ 0.15, n ϭ 24 vs. 2.7 Ϯ 0.2, n ϭ 26, P ϭ not significant) but a markedly reduced FS (2.0 Ϯ 0.5%, n ϭ 24 vs. 5.3 Ϯ 0.5%, n ϭ 12, P Ͻ 0.0001). ] i transient has also been reported in some nonmurine cardiac hypertrophy models (11, 14) and may be due to increased Ca 2ϩ influx due to sarcolemmal stress (12, 18) . It is possible that knockout of the MLP could alter sarcolemmal stresses by inducing changes in the attachment of sarcomeres to the sarcolemma. This would be consistent with the curved appearance of freshly dissociated MLPKO myocytes and the abnormal organization of sarcomeres we detected in phalloidin-stained cells. Our studies in vivo (2, 3, 10) . This could result in a progression of the failure phenotype.
Causes and significance of reduced [Ca 2ϩ ] i -induced shortening. The nonhypertrophied myocytes we studied had a reduced unloaded shortening relative to peak [Ca 2ϩ ] i during a single action potential (Fig. 4 and Tables 3 and 4 ). This finding is consistent with the hypothesis of Olson et al. (20) : that cytoskeletal mutations may produce failure by altering transmission of force from the myofilaments to the sarcolemma. Also in support of this hypothesis, Papp et al. (22) recently demonstrated that degradation of the cytoskeletal protein desmin by calpain-I decreases Ca-dependent force development in permeabilized ventricular myocytes.
In MLPKO mice, we suggest that the genetic defect in the cytoskeleton also results in a decrease in force development in the cell not due to a decrease in the [Ca 2ϩ ] i transient but to altered force transmission from the contractile elements to the sarcolemma. Although under basal conditions the magnitude of unloaded shortening of MLPKO myocytes was similar to that of WT cells due to the increased magnitude of the MLPKO [Ca 2ϩ ] i transient, we suspect that in the intact MLPKO heart in which myocyte loading is significant, this defect results in impaired force of contraction. This would certainly be consistent with the reduced systolic function noted in MLPKO animals by echocardiographic techniques (1, 24) . In this setting, an increase in [Ca 2ϩ ] i might be expected to compensate for the defect. Indeed, the increase in peak [Ca 2ϩ ] i we noted may partially but insufficiently compensate in vivo. This hypothesis is supported by recent work showing that genetically engineered enhancement of SR function by ␤-adrenergic receptor kinase-1 (BARK-1) inhibition (24) or by PLB ablation (17) can prevent the development of the heart failure phenotype in MLPKO mice. It is important to note that rescue of the failure phenotype by enhancement of SR function does not necessarily mean that impaired SR function is the primary cause of the initiation of the failure phenotype. Impaired force production resulting from a variety of processes would be expected in response to a marked increase in the magnitude of the [Ca 2ϩ ] i transient. Indeed, in preliminary a study of 17 myocytes from 2 double knockout animals (PLB and MLP, Ref. 17) we found a peak F/F o of 5.4 Ϯ 0.3 and a FS of 12.5 Ϯ 1.2%, which contrasts with WT values of 2.6 Ϯ 0.12 and 6.5 Ϯ 0.8%, respectively (Table 3) . Thus rescue of the failure phenotype in these animals may require substantial enhancement of SR function relative to normal. This idea is consistent with the observation of Minamisawa et al. (17) that the peak left ventricular dP/dt in double knockout animals was significantly greater than that in WT animals.
The difference in our and Minamisawa et al. (17) findings regarding the magnitude of [Ca 2ϩ ] i transients in MLPKO myocytes may be due in part to our use of BDM in the dissociation process. The presence of BDM reduces myocyte injury due to Ca 2ϩ overload and increases myocyte yield after collagenase dissociation of myocardial tissue (23) . Thus reduced injury of already damaged and fragile failing MLPKO myocytes might be expected to improve the [Ca 2ϩ ] i transient. BDM is also a nonenzymatic phosphatase (9). Marx et al. (15) recently reported that hyperphosphorylation of the ryanodine receptor in failing hearts may cause defective Ca 2ϩ regulation by causing dissociation of FK506-binding protein from the ryanodine receptor. It is theoretically possible that BDM improves SR Ca 2ϩ release in failing hearts by its phosphatase action. In any event, our finding of normal to enhanced SR function in nonhypertrophied MLPKO myocytes isolated in the presence of BDM strongly suggests that impaired SR Ca 2ϩ -ATPase function is not the primary cause of heart failure in this genetic model. Further studies in this model will be required to determine the mechanisms of the increased [Ca 2ϩ ] i transient, whether it is a compensatory process or part of the pathogenesis of failure that develops in these animals, and the nature of secondary effects on myocytes that may contribute to progression of heart failure.
